Advanced adenomas help predict risk after negative surveillance
-
April 2
"The results of this study can aid endoscopists in decision-making surrounding interval follow-up."
Browse By
Navigating primary sclerosing cholangitis: Diagnosis and the 5 pillars of management
-
February 1
-
by Judy A. Trieu, MD, MPH, Mahesh Krishna, MD, David N. Assis, MD
Primary sclerosing cholangitis remains a challenging disease to diagnose and manage, due to varying presentations, associated disease processes, and lack of targeted treatment.
With a little help from my friends: What gastrointestinal pathologists need to know from gastroenterologists
-
February 1
-
by Raul S. Gonzalez, MD
Why better communication between gastroenterologists and pathologists matters for patient care.
Green endoscopy: Practical strategies to reduce environmental impact in GI practice
-
February 1
-
by Rabia de Latour, MD
There are plenty of opportunities for gastroenterologists, ambulatory surgery centers, endoscopy units, and outpatient clinics to implement changes that reduce GHG emissions.
The Latest
Case study: Gastric ulcer mimicking malignancy
-
by Amy Pfeiffer
In patients with gastric ulcers suspicious for malignancy but lacking histologic confirmation, IgG4-related disease should be considered.
Advanced adenomas help predict risk after negative surveillance
-
by Matthew Solan
"The results of this study can aid endoscopists in decision-making surrounding interval follow-up."
Rewriting the gut–brain story with Dr. Trisha Pasricha
-
by Sierra Rendon
The BIDMC Gut-Brain Institute director blends research, journalism, and stigma-busting education.
Gluten found to trigger immune response at very low doses
-
by Doug Brunk
Even trace exposures below labeling standards activate immune pathways while symptoms fail to signal risk.
Subcutaneous guselkumab shows strong remission in phase 3 UC trial
-
by Jess Allerton
"Guselkumab provides an excellent choice for patients and clinicians where safety, efficacy, and convenience are priorities.”